Australia markets open in 9 hours 13 minutes

CStone Pharmaceuticals (CSPHF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.12000.0000 (0.00%)
As of 09:30AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 176.11M
Enterprise value 82.92M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.32
Price/book (mrq)2.38
Enterprise value/revenue 0.18
Enterprise value/EBITDA -0.28

Trading information

Stock price history

Beta (5Y monthly) 0.17
52-week change 3-74.47%
S&P500 52-week change 325.59%
52-week high 30.4700
52-week low 30.1190
50-day moving average 30.1353
200-day moving average 30.2646

Share statistics

Avg vol (3-month) 395
Avg vol (10-day) 3N/A
Shares outstanding 51.28B
Implied shares outstanding 61.47B
Float 8629.24M
% held by insiders 147.70%
% held by institutions 114.18%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -79.17%
Operating margin (ttm)-173.74%

Management effectiveness

Return on assets (ttm)-22.94%
Return on equity (ttm)-81.05%

Income statement

Revenue (ttm)463.84M
Revenue per share (ttm)0.37
Quarterly revenue growth (yoy)-7.80%
Gross profit (ttm)N/A
EBITDA -586.64M
Net income avi to common (ttm)-367.23M
Diluted EPS (ttm)-0.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.05B
Total cash per share (mrq)0.82
Total debt (mrq)363.45M
Total debt/equity (mrq)79.56%
Current ratio (mrq)1.56
Book value per share (mrq)0.36

Cash flow statement

Operating cash flow (ttm)-588.84M
Levered free cash flow (ttm)-511.62M